Glaucomatous visual field progression with frequency-doubling technology and standard automated perimetry in a longitudinal prospective study

Investigative Ophthalmology and Visual Science

Volumn 46, Issue 2, 2005, Pages 547-554

  Haymes, Sharon A ^a   Hutchison, Donna M ^a   McCormick, Terry A ^a   Varma, Devesh K ^a   Nicolela, Marcelo T ^a   Leblanc, Raymond P ^a   Chauhan, Balwantray C ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANALYTIC METHOD; ARTICLE; AUTOMATION; CALCULATION; FEMALE; FREQUENCY DOUBLING TECHNOLOGY; GLAUCOMA; GLAUCOMA CHANGE PROBABILITY; HUMAN; INTERMETHOD COMPARISON; LINEAR REGRESSION ANALYSIS; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; PERIMETRY; PRIORITY JOURNAL; PROBABILITY; PROSPECTIVE STUDY; SENSITIVITY ANALYSIS; STANDARD; TECHNOLOGY; VISUAL FIELD;

DISEASE PROGRESSION; FEMALE; GLAUCOMA, OPEN-ANGLE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; OPTIC NERVE DISEASES; PERIMETRY; PROSPECTIVE STUDIES; RETINAL GANGLION CELLS; VISION DISORDERS; VISUAL FIELDS;

EID: 13944263171     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.04-0973     Document Type: Article

References (41)

1. Heijl A, Lindgren A, Lindgren G. Test-retest variability in glaucomatous visual fields. Am J Ophthalmol. 1989;108:130-135.
2. Chauhan BC, Johnson CA. Test-retest variability of frequency-doubling perimetry and conventional perimetry in glaucoma patients and normal subjects. Invest Ophthalmol Vis Sci. 1999;40: 648-656.
3. Quigley HA, Dunkelberger GR, Green WR. Retinal ganglion cell atrophy correlated with automated perimetry in human eyes with glaucoma. Am J Ophthalmol. 1989;107:453-464.
4. Kerrigan-Baumrind LA, Quigley HA, Pease ME, Kerrigan DF, Mitchell RS. Number of ganglion cells in glaucoma eyes compared with threshold visual field tests in the same persons. Invest Ophthalmol Vis Sci. 2000;41:741-748.
5. Harwerth RS, Crawford ML, Frishman LJ, et al. Visual field defects and neural losses from experimental glaucoma. Prog Retin Eye Res. 2002;21:91-125.
6. Maddess T, Henry GH. Performance of nonlinear visual units in ocular hypertension and glaucoma. Clin Vis Sci. 1992;7:371-383.
7. Johnson CA, Samuels SJ. Screening for glaucomatous visual field loss with frequency-doubling perimetry. Invest Ophthalmol Vis Sci. 1997;38:413-425.
8. Kelly DH. Frequency doubling in visual responses. J Opt Soc Am. 1966;56:1628-1633.
9. Kelly DH. Nonlinear visual responses to flickering sinusoidal gratings. J Opt Soc Am. 1981;71:1051-1055.
10. Spry PG, Johnson CA, McKendrick AM, Turpin A. Variability components of standard automated perimetry and frequency-doubling technology perimetry. Invest Ophthalmol Vis Sci. 2001;42:1404-1410.
11. Sponsel WE, Arango S, Trigo Y, Mensah J. Clinical classification of glaucomatous visual field loss by frequency doubling perimetry. Am J Ophthalmol. 1998;125:830-836.
12. Quigley HA. Identification of glaucoma-related visual field abnormality with the screening protocol of frequency doubling technology. Am J Ophthalmol. 1998;125:819-829.
13. Cello KE, Nelson-Quigg JM, Johnson CA. Frequency doubling technology perimetry for detection of glaucomatous visual field loss. Am J Ophthalmol. 2000;129:314-322.
14. Wadood AC, Azuara-Blanco A, Aspinall P, Taguri A, King AJ. Sensitivity and specificity of frequency-doubling technology, tendency-oriented perimetry, and Humphrey Swedish interactive threshold algorithm-fast perimetry in a glaucoma practice. Am J Ophthalmol. 2002;133:327-332.
15. Bayer AU, Erb C. Short wavelength automated perimetry, frequency doubling technology perimetry, and pattern electroretinography for prediction of progressive glaucomatous standard visual field defects. Ophthalmology. 2002;109:1009-1017.
16. Landers JA, Goldberg I, Graham SL. Detection of early visual field loss in glaucoma using frequency-doubling perimetry and short-wavelength automated perimetry. Arch Ophthalmol. 2003;121: 1705-1710.
17. Medeiros FA, Sample PA, Weinreb RN. Frequency doubling technology perimetry abnormalities as predictors of glaucomatous visual field loss. Am J Ophthalmol. 2004;137:863-871.
18. Artes PH, Nicolela MT, McCormick TA, LeBlanc RP, Chauhan BC. Effects of blur and repeated testing on sensitivity estimates with frequency doubling perimetry. Invest Ophthalmol Vis Sci. 2003; 44:646-652.
19. Heijl A. Humphrey Field Analyzer. In: Drance SM, Anderson DR, eds. Automatic Perimetry in Glaucoma. A Practical Guide. Orlando, FL: Grune and Stratton; 1985:129-140.
20. Heijl A, Lindgren G, Lindgren A, et al. Extended empirical statistical package for evaluation of single and multiple fields: Statpac 2. In: Mills RP, Heijl A, eds. Perimetry Update 1990/1991. New York: Kugler & Ghedini; 1991:303-315.
21. Holmin C, Krakau CE. Regression analysis of the central visual field in chronic glaucoma cases: a follow-up study using automatic perimetry. Acta Ophthalmol (Copenh). 1982;60:267-274.
22. Heijl A, Lindgren G, Olsson J. A package for the statistical analysis of visual fields. Doc Ophthalmol Proc Ser. 1986;49:153-168.
23. Maddess T, Hemmi JM, James AC. Evidence for spatial aliasing effects in the Y-like cells of the magnocellular visual pathway. Vision Res. 1998;38:1843-1859.
24. White AJ, Sun H, Swanson WH, Lee BB. An examination of physiological mechanisms underlying the frequency-doubling illusion. Invest Ophthalmol Vis Sci. 2002;43:3590-3599.
25. Anderson AJ, Johnson CA. Mechanisms isolated by frequency-doubling technology perimetry. Invest Ophthalmol Vis Sci. 2002; 43:398-401.
26. Quigley HA, Dunkelberger GR, Green WR. Chronic human glaucoma causing selectively greater loss of large optic nerve fibers. Ophthalmology. 1988;95:357-363.
27. Johnson CA. Selective versus nonselective losses in glaucoma. J Glaucoma. 1994;3(suppl):S32-S44.
28. Sample PA, Bosworth CF, Blumenthal EZ, Girkin C, Weinreb RN. Visual function-specific perimetry for indirect comparison of different ganglion cell populations in glaucoma. Invest Ophthalmol Vis Sci. 2000;41:1783-1790.
29. Perry VH, Oehler R, Cowey A. Retinal ganglion cells that project to the dorsal lateral geniculate nucleus in the macaque monkey. Neuroscience. 1984;12:1101-1123.
30. Johnson CA. The Glenn A. Fry Award Lecture. Early losses of visual function in glaucoma. Optom Vis Sci. 1995;72:359-370.
31. Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures. Collaborative Normal-Tension Glaucoma Study Group. Am J Ophthalmol. 998;126:487-497.
32. Vesti E, Johnson CA, Chauhan BC. Comparison of different methods for detecting glaucomatous visual field progression. Invest Ophthalmol Vis Sci. 2003;44:3873-3879.
33. Lee AC, Sample PA, Blumenthal EZ, et al. Infrequent confirmation of visual field progression. Ophthalmology. 2002;109:1059-1065.
34. Smith SD, Katz J, Quigley HA. Analysis of progressive change in automated visual fields in glaucoma. Invest Ophthalmol Vis Sci. 1996;37:1419-1428.
35. Nouri-Mahdavi K, Brigatti L, Weitzman M, Caprioli J. Comparison of methods to detect visual field progression in glaucoma. Ophthalmology. 1997;104:1228-1236.
36. Spry PG, Johnson CA. Identification of progressive glaucomatous visual field loss. Surv Ophthalmol. 2002;47:158-173.
37. McNaught AI, Crabb DP, Fitzke FW, Hitchings RA. Visual field progression: comparison of Humphrey Statpac2 and pointwise linear regression analysis. Graefes Arch Clin Exp Ophthalmol. 1996;234:411-418.
38. Mikelberg FS, Schulzer M, Drance SM, Lau W. The rate of progression of scotomas in glaucoma. Am J Ophthalmol. 1986;101:1-6.
39. McNaught AI, Crabb DP, Fitzke FW, Hitchings RA. Modelling series of visual fields to detect progression in normal-tension glaucoma. Graefes Arch Clin Exp Ophthalmol. 1995;233:750-755.
40. Rasker MT, van den Enden A, Bakker D, Hoyng PF. Rate of visual field loss in progressive glaucoma. Arch Ophthalmol. 2000;118: 481-488.
41. Viswanathan AC, Fitzke FW, Hitchings RA. Early detection of visual field progression in glaucoma: a comparison of PROGRESSOR and STATPAC 2. Br J Ophthalmol. 1997;81:1037-1042.